Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2011 Dec;63(12):1672–1679. doi: 10.1002/acr.20643

Figure 2.

Figure 2

Level of disease activity* at which RA patients switched their biologic treatment regimen, by calendar year

* measured by the clinical disease activity index (CDAI); the thresholds for low, moderate, and high disease activity for CDAI are <= 10, between 10 and 22, and >= 22